Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
40.95 USD | -0.66% | -4.12% | -14.28% |
May. 03 | Wedbush Adjusts Ultragenyx Pharmaceutical's Price Target to $47 From $48, Keeps Neutral Rating | MT |
May. 02 | Transcript : Ultragenyx Pharmaceutical Inc., Q1 2024 Earnings Call, May 02, 2024 |